β2-adrenergic receptor antagonist (trial agent)

· Trio Medicines Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for β2-adrenergic receptor antagonist (trial agent), covering 2025-12-09 to 2025-12-09. Get the full timeline:

Most recent: Clinical Trial Update: Selective β2-AR Antagonism in Asthma [Phase 1]